Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.80 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.80 |
| ▸ | RAB9A | P51151 | 10/20 | 0.77 |
| ▸ | NPC1 | O15118 | 9/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.64 |
| ▸ | TP53 | P04637 | 3/20 | 0.64 |
| ▸ | DDX3X | O00571 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | XBP1 | P17861 | 1/20 | 0.61 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28791190 | 1.00 | CSNK2A2 (0.80) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL22532425 | 0.89 | CSNK2A2 (0.62) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL17318637 | 0.89 | CSNK2A2 (0.81) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL28791192 | 0.88 | CSNK2A2 (0.80) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL17318701 | 0.88 | CSNK2A2 (0.80) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL17318624 | 0.86 | RAB9A (0.79) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL28791198 | 0.85 | CSNK2A2 (0.76) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL18762150 | 0.82 | BLM (0.70) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL28791183 | 0.81 | NPC1 (0.70) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A | |
| SCHEMBL3668829 | 0.80 | DGAT1 (0.74) | CSNK2A2CSNK2A1RAB9ANPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114060-A1 | NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114060-A1 | NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME | ZC3HAV1, MAVS, EIF2AK2 | CSNK2A2 2710/4885CSNK2A1 2596/4885RAB9A 1296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.